Zinan Yi

8PUBLICATIONS
6CO-AUTHORS
Pacific Peoples health policyPreventative health careEconomic development policyPolitical economy and social changeMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 06, 2026
Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany.

|Sep 11, 2026
Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21.

|May 19, 2026
Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis.

|Feb 18, 2026
Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland.

Muloongo Simuzingili, Andrea Favre-Bulle, Thomas Mutschler

|Dec 10, 2025
Estimating the Health and Economic Burden of Pneumococcal Diseases Attributable to PCV21 Versus PCV20 or PPSV23 Serotypes Among Adults in Norway.

Zinan Yi, Athar Ali Tajik, Søren Toksvig Klitkou

|Apr 24, 2025
Economic evaluation of PCV21 in vaccine-naïve adults aged 19-64 years with underlying medical conditions in the United States.

Zinan Yi, Elamin H Elbasha, Kwame Owusu-Edusei

Pageof 2

Frequent Collaborators

4 joint publications

Kwame Owusu-Edusei

2 joint publications

Andrea Favre-Bulle

2 joint publications

Eleana Tsoumani

2 joint publications

Muloongo Simuzingili